Kami J. Maddocks

Kami J. Maddocks conducts clinical research on blood cancers, with a particular focus on lymphomas such as mantle cell lymphoma, follicular lymphoma, marginal zone lymphoma, and Hodgkin lymphoma. This work centers on evaluating new drugs and treatment combinations—including BTK inhibitors (drugs that block a signaling protein important for cancer cell survival), CAR-T cell therapy, and antibody-based treatments—largely through clinical trials. Prospective students would likely be involved in analyzing trial data, treatment outcomes, and drug resistance mechanisms in lymphoma patients.

Publication output has grown over the past decade, rising from under 20 papers per year in 2017 to a peak of 66 in 2023, with recent years settling at a still-substantial pace of around 24-25 per year.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026